Nab-paclitaxel Combined With Cadonilimab (AK104) for the Second-line Treatment of Advanced Gastric Cancer
Conditions: Gastric Cancer Interventions: Drug: Nab-paclitaxel Combined With Cadonilimab (AK104) Sponsors: West China Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | China Health | Gastric (Stomach) Cancer | Gastroenterology | Hospitals | Research